This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why You Should Retain QuidelOrtho (QDEL) Stock For Now
by Zacks Equity Research
Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio.
Here's Why Investors Should Retain Cerner (CERN) Stock Now
by Zacks Equity Research
Cerner (CERN) continues to gain traction from its robust strategic deals. However, stiff competition remains a woe.
Stryker's (SYK) Q Guidance System Receives FDA Approval
by Zacks Equity Research
Stryker's (SYK) Q Guidance System is expected to be a procedural ecosystem for surgeons during image-guided surgery following the receipt of the FDA approval.
Thermo Fisher (TMO) North America Sales Grow, Margin Woe Stays
by Zacks Equity Research
Thermo Fisher (TMO) witnesses core business strength across segments, end markets, and geographies.
Reasons to Retain Integer Holdings (ITGR) Stock For Now
by Zacks Equity Research
Investors continue to be optimistic about Integer Holdings (ITGR) owing to its improving non-medical sales and solid foothold in the broader MedTech space.
Factors that Make UnitedHealth Group (UNH) an Attractive Bet Now
by Zacks Equity Research
UnitedHealth Group (UNH) continues to benefit from sustained top-line growth, a growing membership, and a strong cash position.
Here's Why Investors Should Retain Illumina (ILMN) Stock Now
by Zacks Equity Research
Investors are optimistic about Illumina's (ILMN) better-than-expected results and revenue contributions from the GRAIL business.
Wall Street Analysts See a 44% Upside in AMN Healthcare (AMN): Can the Stock Really Move This High?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 43.7% in AMN Healthcare (AMN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Here's Why You Should Retain PerkinElmer (PKI) Stock Now
by Zacks Equity Research
PerkinElmer (PKI) continues to gain momentum from a solid product portfolio and healthy margins. However, forex woes linger.
Zacks.com featured highlights include Tecnoglass, AMN Healthcare Services, Cumulus Media, and Universal Logistics Holdings
by Zacks Equity Research
Tecnoglass, AMN Healthcare Services, Cumulus Media, and Universal Logistics Holdings are part of Screen of the Week article.
Tandem Diabetes (TNDM) Pump Shipment Recovers, Price Issue Ails
by Zacks Equity Research
Tandem Diabetes (TNDM) witnesses strong customer retention, driven by the impressive positive response from the Control-IQ technology.
Integra (IART) Gains From Innovation Amid Cost Constraints
by Zacks Equity Research
Integra's (IART) international sales in CSS grow led by the strong performance of CereLink in Europe and growth in Asia.
AMN Healthcare (AMN) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
AMN Healthcare (AMN) is well positioned to outperform the market, as it exhibits above-average growth in financials.
CVS Health (CVS) to Improve Primary Care With New Offering
by Zacks Equity Research
CVS Health (CVS) debuts the new CVS Health Virtual Primary Care solution to allow consumers to obtain care whenever necessary.
NextGen Healthcare (NXGN) Unveils Health Data Hub Insights
by Zacks Equity Research
NextGen Healthcare's (NXGN) newly launched tool can help healthcare providers to receive a complete picture of the community and patient health.
Here's Why You Should Retain Merit Medical (MMSI) Stock Now
by Zacks Equity Research
Investors continue to be optimistic about Merit Medical (MMSI) due to its strong product portfolio.
Reasons to Add AMN Healthcare (AMN) Stock to Your Portfolio
by Zacks Equity Research
Investors remain optimistic about AMN Healthcare (AMN) on its broad array of services.
4 Stocks With Robust Net Profit Margin to Enhance Your Returns
by Anirudha Bhagat
Let's take a look at these four top-ranked stocks - TGLS, AMN, CMLS and ULH - with impressive net profit margins for a winning portfolio.
Zacks.com featured highlights Canadian Natural Resources, AutoNation and AMN Healthcare Services
by Zacks Equity Research
Canadian Natural Resources, AutoNation and AMN Healthcare Services have been highlighted in this Screen of the Week article.
Walgreens Boots (WBA) Omnichannel Aids Growth Amid Cost Woes
by Zacks Equity Research
The continued acceleration of Walgreens' (WBA) omnichannel offerings and a significant rise in MyWalgreens membership are notable upsides in recent times.
Medtronic's (MDT) Q4 Earnings and Revenues Lag Estimates
by Zacks Equity Research
On a positive note, Medtronic (MDT) registers organic growth in the Cardiovascular and Neuroscience segments.
Change Healthcare (CHNG) Q4 Earnings Miss Estimates, Revenues Top
by Zacks Equity Research
Change Healthcare's (CHNG) fiscal fourth-quarter results benefit from solid performance across Software and Analytics, Network Solutions and Technology-Enabled segments.
Cooper Companies (COO) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Cooper Companies' (COO) fiscal second-quarter results are likely to reflect segmental strength.
Abbott (ABT) to Commence Limited Release of EleCare Soon
by Zacks Equity Research
Abbott's (ABT) release of limited quantities of EleCare branded specialty formulas to be free of charge to children in need.
The Zacks Analyst Blog Highlights Global Water Resources, Vistra, Archer-Daniels-Midland, Pilgrim's Pride and AMN Healthcare Services
by Zacks Equity Research
Global Water Resources, Vistra, Archer-Daniels-Midland, Pilgrim's Pride and AMN Healthcare Services have been included in this Analyst Blog.